Lupin intimates of successful PAI USFDA inspection of Goa facility
Without any observations
Lupin announced the successful completion of a PAI inspection (Prior Approval Inspection) carried out by the USFDA at its Goa manufacturing facility without any observations. The inspection which started on 17 July 2017 concluded on 21 July 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content